BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 30139824)

  • 1. Long-term Effects of Growth Hormone Replacement Therapy in Childhood-onset Craniopharyngioma: Results of the German Craniopharyngioma Registry (HIT-Endo).
    Boekhoff S; Bogusz A; Sterkenburg AS; Eveslage M; Müller HL
    Eur J Endocrinol; 2018 Oct; 179(5):331-341. PubMed ID: 30139824
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Baseline characteristics and response to 2 years of growth hormone (GH) replacement of hypopituitary patients with GH deficiency due to adult-onset craniopharyngioma in comparison with patients with nonfunctioning pituitary adenoma: data from KIMS (Pfizer International Metabolic Database).
    Verhelst J; Kendall-Taylor P; Erfurth EM; Price DA; Geffner M; Koltowska-Häggström M; Jönsson PJ; Wilton P; Abs R
    J Clin Endocrinol Metab; 2005 Aug; 90(8):4636-43. PubMed ID: 15928246
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Survival, hypothalamic obesity, and neuropsychological/psychosocial status after childhood-onset craniopharyngioma: newly reported long-term outcomes.
    Sterkenburg AS; Hoffmann A; Gebhardt U; Warmuth-Metz M; Daubenbüchel AM; Müller HL
    Neuro Oncol; 2015 Jul; 17(7):1029-38. PubMed ID: 25838139
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical characteristics and effects of GH replacement therapy in adults with childhood-onset craniopharyngioma compared with those in adults with other causes of childhood-onset hypothalamic-pituitary dysfunction.
    Yuen KC; Koltowska-Häggström M; Cook DM; Fox JL; Jönsson PJ; Geffner ME; Abs R
    Eur J Endocrinol; 2013 Oct; 169(4):511-9. PubMed ID: 23904277
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quality of life and growth after childhood craniopharyngioma: results of the multinational trial KRANIOPHARYNGEOM 2007.
    Heinks K; Boekhoff S; Hoffmann A; Warmuth-Metz M; Eveslage M; Peng J; Calaminus G; Müller HL
    Endocrine; 2018 Feb; 59(2):364-372. PubMed ID: 29230635
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Growth hormone treatment in pituitary insufficiency: selected cases of children with craniopharyngioma and medulloblastoma.
    Kedzia A; Obara-Moszyńska M; Korman E; Rabska-Pietrzak B; Kopinski P; Trojan J; Goździcka-Józefiak A
    Rocz Akad Med Bialymst; 2003; 48():28-33. PubMed ID: 14737937
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypothalamic involvement predicts cardiovascular risk in adults with childhood onset craniopharyngioma on long-term GH therapy.
    Holmer H; Ekman B; Björk J; Nordstöm CH; Popovic V; Siversson A; Erfurth EM
    Eur J Endocrinol; 2009 Nov; 161(5):671-9. PubMed ID: 19667040
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relative Risks of Contributing Factors to Morbidity and Mortality in Adults With Craniopharyngioma on Growth Hormone Replacement.
    Yuen KCJ; Mattsson AF; Burman P; Erfurth EM; Camacho-Hubner C; Fox JL; Verhelst J; Geffner ME; Abs R
    J Clin Endocrinol Metab; 2018 Feb; 103(2):768-777. PubMed ID: 29029108
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patients with craniopharyngiomas: therapeutical difficulties with growth hormone.
    Cannavò S; Marini F; Trimarchi F
    J Endocrinol Invest; 2008 Sep; 31(9 Suppl):56-60. PubMed ID: 19020388
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Childhood craniopharyngioma with hypothalamic obesity - no long-term weight reduction due to rehabilitation programs].
    Sterkenburg AS; Hoffmann A; Gebhardt U; Waldeck E; Springer S; Müller HL
    Klin Padiatr; 2014 Nov; 226(6-7):344-50. PubMed ID: 25431867
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nuchal Skinfold Thickness: A Novel Parameter for Assessment of Body Composition in Childhood Craniopharyngioma.
    Sterkenburg AS; Hoffmann A; Reichel J; Lohle K; Eveslage M; Warmuth-Metz M; Müller HL
    J Clin Endocrinol Metab; 2016 Dec; 101(12):4922-4930. PubMed ID: 27680877
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HORMONE SUBSTITUTION AFTER GASTRIC BYPASS SURGERY IN PATIENTS WITH HYPOPITUITARISM SECONDARY TO CRANIOPHARYNGIOMA.
    Wolf P; Winhofer Y; Smajis S; Kruschitz R; Schindler K; Gessl A; Riedl M; Vila G; Raber W; Langer F; Prager G; Ludvik B; Luger A; Krebs M
    Endocr Pract; 2016 May; 22(5):595-601. PubMed ID: 26789341
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aspects of growth hormone deficiency and replacement in elderly hypopituitary adults.
    Feldt-Rasmussen U; Wilton P; Jonsson P; ;
    Growth Horm IGF Res; 2004 Jun; 14 Suppl A():S51-8. PubMed ID: 15135778
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of Childhood-onset Craniopharyngioma in Italy: A Multicenter, 7-Year Follow-up Study of 145 Patients.
    Zucchini S; Di Iorgi N; Pozzobon G; Pedicelli S; Parpagnoli M; Driul D; Matarazzo P; Baronio F; Crocco M; Iudica G; Partenope C; Nardini B; Ubertini G; Menardi R; Guzzetti C; Iughetti L; Aversa T; Di Mase R; Cassio A;
    J Clin Endocrinol Metab; 2022 Feb; 107(3):e1020-e1031. PubMed ID: 34718649
    [TBL] [Abstract][Full Text] [Related]  

  • 15. History before diagnosis in childhood craniopharyngioma: associations with initial presentation and long-term prognosis.
    Hoffmann A; Boekhoff S; Gebhardt U; Sterkenburg AS; Daubenbüchel AM; Eveslage M; Müller HL
    Eur J Endocrinol; 2015 Dec; 173(6):853-62. PubMed ID: 26392473
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Craniopharyngioma: long-term consequences of a chronic disease.
    Müller HL
    Expert Rev Neurother; 2015; 15(11):1241-4. PubMed ID: 26523617
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hydrocephalus and hypothalamic involvement in pediatric patients with craniopharyngioma or cysts of Rathke's pouch: impact on long-term prognosis.
    Daubenbüchel AM; Hoffmann A; Gebhardt U; Warmuth-Metz M; Sterkenburg AS; Müller HL
    Eur J Endocrinol; 2015 May; 172(5):561-9. PubMed ID: 25650403
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nonalcoholic fatty liver disease and fatigue in long-term survivors of childhood-onset craniopharyngioma.
    Hoffmann A; Bootsveld K; Gebhardt U; Daubenbüchel AM; Sterkenburg AS; Müller HL
    Eur J Endocrinol; 2015 Sep; 173(3):389-97. PubMed ID: 26088821
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analyses of treatment variables for patients with childhood craniopharyngioma--results of the multicenter prospective trial KRANIOPHARYNGEOM 2000 after three years of follow-up.
    Müller HL; Gebhardt U; Schröder S; Pohl F; Kortmann RD; Faldum A; Zwiener I; Warmuth-Metz M; Pietsch T; Calaminus G; Kolb R; Wiegand C; Sörensen N;
    Horm Res Paediatr; 2010; 73(3):175-80. PubMed ID: 20197669
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Obesity after childhood craniopharyngioma--German multicenter study on pre-operative risk factors and quality of life.
    Müller HL; Bueb K; Bartels U; Roth C; Harz K; Graf N; Korinthenberg R; Bettendorf M; Kühl J; Gutjahr P; Sörensen N; Calaminus G
    Klin Padiatr; 2001; 213(4):244-9. PubMed ID: 11528558
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.